Daily Cosmetic Research Analysis
Analyzed 22 papers and selected 3 impactful papers.
Summary
Analyzed 22 papers and selected 3 impactful articles.
Selected Articles
1. Mechanisms underlying the protective effects of San-Bai decoction against UV radiation on the skin.
An integrated systems pharmacology, 3D pigmented skin model, and double-blind, placebo-controlled clinical study demonstrated that a 5% aqueous San-Bai decoction extract (USBT2627) protects skin from UV damage. Significant improvements in L and ITA° and reduced erythema were observed, alongside transcriptomic modulation of pigmentation, oxidative stress, and cytokine signaling pathways.*
Impact: Combining mechanistic omics with a blinded clinical study provides translational evidence for a topical botanical photoprotectant, informing formulation science and cosmetic dermatology.
Clinical Implications: Supports development of evidence-based topical photoprotectants; suggests measurable colorimetric endpoints (L*, ITA°, a*) and pathway targets (ET-1, oxidative stress) for formulation optimization and trial design.
Key Findings
- In a double-blind, placebo-controlled study, 5% USBT2627 increased L* (p=0.048) and ITA° (p=0.022) and reduced erythema (p=0.016) after UV exposure.
- USBT2627 suppressed melanin accumulation in a pigmented living skin equivalent model.
- Transcriptomics indicated modulation of endothelin-1 signaling, pigmentation pathways, oxidative responses, and cytokine signaling.
- Network pharmacology linked >800 putative targets to SBD components, enriched for oxidative and immune regulation.
Methodological Strengths
- Double-blind, placebo-controlled clinical evaluation with objective colorimetric endpoints
- Integrated in silico network pharmacology, in vitro 3D skin model, and transcriptomics
Limitations
- Clinical sample size and duration are not reported, limiting generalizability and long-term inference
- Single-extract, single-concentration evaluation limits dose-response and comparative benchmarking
Future Directions: Conduct larger, multi-ethnic RCTs with longer follow-up, dose-ranging, and head-to-head comparisons with established photoprotectants; validate mechanistic signatures (ET-1, oxidative pathways) as predictive biomarkers.
BACKGROUND: San-Bai decoction (SBD), as a classic TCM formula, has been administered orally to support skin health with a long record history dating back to the Ming Dynasty in China. However, the protective efficacy of SBD through topical application on skin remains unclear. PURPOSE: We aimed to evaluate the effectiveness of SBD in protecting skin against UV radiation through an integrated in silico-in vitro-in vivo framework and elucidate its underlying mechanisms using a systems biology approach. METHODS: A public database was used to construct a network diagram linking SBD's active chemical components with corresponding potential target genes for network pharmacology analysis. Skin lightening efficacy was evaluated in vitro using a pigmented 3D skin model, while in vivo protective effects were assessed in a double-blind, placebo-controlled clinical study. Transcriptomic analysis using the microarray platform was conducted to explore underlying mechanisms among control, UV exposure and SBD treatment groups. RESULTS: Network pharmacology analysis implicated over 800 effective targets regulated by SBD, with Gene Ontology enrichment analysis suggesting that they were involved in oxidative response and immune regulation. USBT2627, the aqueous extract of SBD, displayed skin lightening effect in a pigmented living skin equivalent model. Compared with the placebo, pretreatment with 5% USBT2627 effectively protected skin from UV damage, increasing L* values (p = 0.048) and ITA° (p = 0.022), and reducing erythema (p = 0.016). USBT2627 pretreatment also showed a mild effect on a* reduction (p = 0.052). Transcriptomic analysis indicated that USBT2627 regulated multiple pathways related to skin pigmentation, such as ET-1 signalling and pigmentation signalling pathways, as well as oxidation response and cytokine signalling pathways. CONCLUSIONS: USBT2627 suppresses melanin accumulation in vitro and protects skin against UV exposure in both in vitro and in vivo models; multiple components, targets and pathways of SBD act together to confer its protective effect against UV exposure. These findings highlight a significant potential of topical USBT2627 in protecting skin against UV exposure. Additionally, this study showcases the value of a systems network approach in elucidating the mechanisms of this herbal blend, offering valuable references for further research aimed at developing TCM-based products.
2. Effectiveness of chlorhexidine and xylitol varnish versus silver diamine fluoride in the control of initial dental caries lesions: a randomised clinical trial.
In a randomized clinical trial of 5–6-year-olds, both chlorhexidine–xylitol varnish and 30% silver diamine fluoride reduced initial caries, with SDF demonstrating greater efficacy. Participant blinding was implemented; VCX may be preferable in cases where aesthetic concerns (e.g., staining) are paramount.
Impact: Provides comparative clinical evidence balancing caries arrest efficacy against aesthetic trade-offs, informing family-centered decision-making in pediatric dentistry.
Clinical Implications: SDF remains first-line for caries arrest due to superior efficacy; VCX can be considered when avoiding discoloration is a priority, pending validation of long-term outcomes and optimized protocols.
Key Findings
- Both VCX (2% chlorhexidine + 5% xylitol varnish) and 30% SDF reduced initial caries in young children.
- SDF showed superior efficacy compared to VCX in controlling initial lesions.
- Participant blinding was feasible, although investigator blinding was not due to material differences.
Methodological Strengths
- Randomized allocation with an untreated control arm
- Standardized lesion assessment using ICDAS-II
Limitations
- Investigator blinding was not possible, introducing potential assessment bias
- Sample size and follow-up duration were not reported, limiting inference on sustainability of effects
Future Directions: Longer-term, adequately powered RCTs with standardized aesthetic outcome measures (e.g., staining scales) to refine protocols and assess durability and acceptability.
AIM: This study aims to compare the effectiveness of a chlorhexidine (2%) and xylitol (5%) varnish (VCX) versus a silver diamine fluoride (SDF) solution (30%) in controlling initial dental caries lesions in young children. METHODS: A randomised clinical trial was conducted with children aged 5 and 6 from public schools in Jequié, Bahia. Participants were randomly assigned to three groups: one treated with VCX, another with SDF, and a control group that received no intervention. Carious lesions were classified using ICDAS-II criteria, and interventions were applied following standardised clinical protocols. Blinding was applied to participants, though not to researchers due to physical differences in treatment materials. CONCLUSION: Both VCX and SDF were effective in reducing initial dental caries lesions, with SDF showing superior efficacy. However, VCX may serve as a viable alternative for patients concerned with aesthetics, though further studies are required to confirm its long-term effectiveness and optimise treatment protocols.
3. Cross-Cultural Beliefs and Stigmatization in Vitiligo: A Systematic Review.
This systematic review of 23 studies reveals substantial cross-cultural variability in beliefs about vitiligo, with pervasive stigma linked to social exclusion and discrimination, especially among women and darker phototypes. Quality-of-life burdens are higher in African, Middle Eastern, and South Asian populations, underscoring the need for culturally tailored, multidisciplinary interventions.
Impact: Synthesizes global psychosocial evidence to guide targeted education, mental health support, and stigma-reduction strategies in cosmetic dermatology practice.
Clinical Implications: Incorporate culturally informed counseling, QoL screening, and community education; prioritize support for higher-risk groups (women, darker phototypes) and regions with limited dermatologic literacy.
Key Findings
- Cultural attributions include contagion, divine punishment, and supernatural causes, especially where health literacy is low.
- Stigmatization manifests as social exclusion and employment/marital discrimination, more severe in women and darker skin phototypes.
- QoL impairment is greater in African, Middle Eastern, and South Asian cohorts versus Western populations.
- Coping strategies commonly include concealment, spiritual reliance, and CAM use.
Methodological Strengths
- Comprehensive multi-database search across medical and psychological literature
- Focus on culturally specific psychosocial domains with cross-regional comparisons
Limitations
- Heterogeneity of study designs and outcomes limits meta-analytic synthesis
- Potential publication and language bias; limited longitudinal data
Future Directions: Prospective, culturally tailored interventions with validated QoL and stigma metrics in high-burden regions; include men and diverse phototypes to refine risk stratification.
BACKGROUND: Vitiligo is an autoimmune condition marked by depigmentation of the skin and is frequently associated with psychosocial distress. Although often dismissed as cosmetic, vitiligo carries a substantial burden influenced by cultural beliefs, stigma, and access to medical education. AIMS: This review aims to examine the literature on cross-cultural beliefs, stigmatization, psychological comorbidities, and quality of life (QoL) outcomes in individuals with vitiligo. METHODS: A comprehensive search of PubMed, Embase, and PsycINFO was conducted to identify peer-reviewed studies discussing cultural beliefs, stigma, psychological burden, or QoL in individuals with vitiligo. Inclusion criteria encompassed original studies in English assessing relevant psychosocial or cultural domains. RESULTS: Twenty-three studies met inclusion criteria. Cultural attributions of vitiligo varied widely, with some populations linking the disease to contagion, divine punishment, or supernatural causes. These beliefs were more prevalent in regions with lower health literacy and limited access to dermatologic care. Stigmatization-manifesting as social exclusion, employment and marital discrimination, and internalized shame-was consistently reported across settings, though more severe in female patients and individuals with darker skin phototypes in certain regions. QoL impairment was greater in African, Middle Eastern, and South Asian populations compared to Western cohorts. Coping strategies included concealment, spiritual reliance, and use of complementary and alternative medicine (CAM). CONCLUSION: Vitiligo imposes a global psychosocial burden that is amplified by cultural misconceptions and stigma. Culturally tailored, multidisciplinary interventions-including education, psychological support, and community-based stigma reduction-are crucial to improving outcomes. Future research should focus on high-stigma, underrepresented populations to inform equitable care.